| Literature DB >> 32901606 |
Samuel R Aquino1,2, Lucyo F B Diniz2, Igor T Queiroz3, Mirella A Cunha4, Alda M Justo5,6, Elis D Silva7, Valéria R A Pereira7, Zulma M Medeiros5,7, Rodrigo F Carmo1,8.
Abstract
We report a case of visceral leishmaniasis (VL)/HIV coinfection in a patient undergoing regular antiretroviral therapy and treatment with thalidomide for erythema nodosum leprosum. He presented at a health service with high fever, chills, asthenia, pale skin, lower limb edema, hepatomegaly, and splenomegaly. Visceral leishmaniasis was confirmed by direct examination, and serological and molecular tests. Serum levels of Th1/Th2 cytokines were measured. The patient began treatment with liposomal amphotericin B, with good clinical response; however, VL recurred 6 months later. Treatment was reinitiated, maintaining secondary prophylaxis with liposomal amphotericin B. The patient showed clinical improvement with important recovery of CD4+ T-lymphocyte count.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32901606 PMCID: PMC7695079 DOI: 10.4269/ajtmh.20-0567
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 3.707